![]() This therapeutic class has long ranked as the top specialty pharmacy area in terms of pharmacy benefit spend for multiple PBMs. And in 2019, Cosentyx was a preferred alternative for the inflammatory conditions class. In a footnote on the exclusion, Cigna explains that “product placement for treatment of Inflammatory Conditions in the Inflammatory Conditions Care Value (ICCV) Program are subject to change throughout the year based upon changes in market dynamics, new indications for existing products, biosimilar and new product launches.” Indeed, in 2020, Taltz was excluded in the inflammatory conditions class, and Cosentyx was a preferred alternative. ![]() Of the preferred therapies, Taltz - a humanized interleukin-17A antagonist indicated for adult and pediatric plaque psoriasis, psoriatic arthritis, ankylosing spondylitis and non-radiographic axial spondyloarthritis - is the only one with the same mechanism of action as Cosentyx. Then they will receive the card in six to eight weeks following the second fill. To qualify for the debit card, patients must fill a prescription for a preferred agent at least once before Aug.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |